Skip to main content
. 2023 Jan;64(1):109–116. doi: 10.2967/jnumed.122.263962

FIGURE 4.

FIGURE 4.

Experiment 3. Significant increase in median survival is seen with 1 dose of 213Bi-rituximab relative to controls and with 2 or 3 doses relative to 1 dose. This study used higher initial tumor inoculation with same timing of first treatment as in study 1. There were no cures in this study.